Immunic, Inc. Common Stock

IMUXNASDAQ • USD
7.36 USD
↗ 0.13 (1.73%)🟢LIVE (AS OF 02:24 PM EST)
🟢Market: OPEN

IMUX is currently priced at $7.36. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, IMUX appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Nov 16, 2026.

Open?$7.26
High?$7.60
Low?$7.07
Prev. Close?$7.23
Volume?116.7K
Avg. Volume?307.8K
VWAP?$7.27
Rel. Volume?0.38x
Bid / Ask
Bid?$6.20 × 100
Ask?$8.41 × 100
Spread?$2.21
Midpoint?$7.31
Valuation & Ratios
Market Cap?114.8M
Shares Out?13.6M
Float?10.7M
Float %?78.3%
P/E Ratio?N/A
P/B Ratio?0.90
EPS?-$7.03
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function. It operates in one segment which is Life science segment.
Employees
95
Market Cap
102.6M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2014-04-17
Address
1200 AVENUE OF THE AMERICAS
NEW YORK, X1 10036
Phone: (332) 255-9818
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
65
Short Sent.?
31
Piotroski F-Score?0/9Weak
Altman Z-Score?-5.25Distress
Confidence?49%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?18.28%High
Short Interest?2.0M
Days to Cover?5.7
Free Float10.7M
Avg Daily Volume340.6K
Settlement Date2026-10-30
Financial Health
Current Ratio?5.05Strong
Quick Ratio?5.05Strong
Cash Ratio?4.96Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.90CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
97
0.3CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-87.5%WEAK▾
ROA?
S&P
3
-70.1%WEAK▾
Cash Flow & Enterprise
FCF?$-88049000
Enterprise Value?$-40279657
Fundamentals ratios updated end of day